World Journal of Experimental Medicine, Journal Year: 2024, Volume and Issue: 14(4)

Published: Oct. 29, 2024

This editorial discusses the insightful minireview by Rahmati et al . The delves into role of aryl hydrocarbon receptor in development and progression esophageal squamous cell carcinoma, highlighting its potential as a promising therapeutic target. authors concisely summarize current understanding how modulation influences immune responses tumor microenvironment, offering fresh perspectives on strategies. aimed to emphasize significance these findings their impact future research clinical practices for management carcinoma.

Language: Английский